<iframe src="//www.googletagmanager.com/ns.html?id=GTM-5TSRKG" height="0" width="0" style="display: none; visibility: hidden">
Research Article
No access
Published Online: 27 December 2018

Expression of Autophagy Signaling Molecules in the Outer Membranes of Chronic Subdural Hematomas

Publication: Journal of Neurotrauma
Volume 36, Issue Number 2

Abstract

Chronic subdural hematoma (CSDH) is fundamentally treatable, although it sometimes recurs. We observed, however, several cases of spontaneous resolution of CSDH outer membranes, even in a trabecular type of CSDH, after a trepanation surgical procedure. In this study, we examined the expression of molecules of the autophagy signaling pathway in CSDH outer membranes. Eight patients whose outer membranes were obtained successfully during trepanation were included in this study. By Western blot analysis, we examined the expression of mammalian target of rapamycin (mTOR); GβL; UNC-51-like kinase-1 (ULK1); Beclin-1; autophagy-related genes (Atg) 3, 5, 7, 12, 13, and 16L1β,α; the autophagy marker Light Chain3A/B (LC3A/B); and β-actin, which constitute the autophagy signaling pathway. The expression levels of Beclin-1, Atg12, and LC3A/B were also examined by immunohistochemistry. Almost all of these molecules could be detected in all samples. Beclin-1, Atg12, and LC3A/B were found to be localized in the endothelial cells of vessels and fibroblasts in CSDH. We detected molecules of the autophagy signaling pathway in CSDH outer membranes. Autophagy contributes to the tissue homeostatic process, maintaining cellular integrity by clearing debris. Our data suggest that autophagy might play an important role in the spontaneous resolution of CSDH. Therefore, these molecules may be novel therapeutic targets for the treatment of those with CSDH.

Get full access to this article

View all available purchase options and get full access to this article.

References

1. Naganuma H., Fukamachi A., Kawakami M., Misumi S., Nakajima H., and Wakao T. (1986). Spontaneous resolution of chronic subdural hematomas. Neurosurgery 19, 794–798.
2. Aoyama M., Osuka K., Usuda N., Watanabe Y., Kawaguchi R., Nakura T., and Takayasu M. (2015). Expression of mitogen-activated protein kinases in chronic subdural hematoma outer membranes. J. Neurotrauma 32, 1064–1070.
3. Funai M., Osuka K., Usuda N., Atsuzawa K., Inukai T., Yasuda M., Watanabe Y., and Takayasu M. (2011). Activation of PI3 kinase/Akt signaling in chronic subdural hematoma outer membranes. J. Neurotrauma 28, 1127–1131.
4. Osuka K., Watanabe Y., Usuda N., Aoyama M., Kawaguchi R., Takeuchi M., and Takayasu M. (2017). Activation of nuclear factor-kappa B in endothelial cells of chronic subdural hematoma outer membranes. Neurosurgery 80, 571–578.
5. Osuka K., Watanabe Y., Usuda N., Aoyama M., Kawaguchi R., Watabe T., and Takayasu M. (2016). Activation of signal transducer and activator of transcription 3 in endothelial cells of chronic subdural hematoma outer membranes. World Neurosurg. 91, 376–382.
6. Osuka K., Watanabe Y., Usuda N., Atsuzawa K., Aoyama M., Niwa A., Nakura T., and Takayasu M. (2012). Activation of Ras/MEK/ERK signaling in chronic subdural hematoma outer membranes. Brain Res. 1489, 98–103.
7. Nakaguchi H., Tanishima T., and Yoshimasu N. (2001). Factors in the natural history of chronic subdural hematomas that influence their postoperative recurrence. J. Neurosurg. 95, 256–262.
8. Ravikumar B., Sarkar S., Davies J.E., Futter M., Garcia-Arencibia M., Green-Thompson Z.W., Jimenez-Sanchez M., Korolchuk V.I., Lichtenberg M., Luo S., Massey D.C., Menzies F.M., Moreau K., Narayanan U., Renna M., Siddiqi F.H., Underwood B.R., Winslow A.R., and Rubinsztein D.C. (2010). Regulation of mammalian autophagy in physiology and pathophysiology. Physiol. Rev. 90, 1383–1435.
9. Kim D.H., Sarbassov D.D., Ali S.M., Latek R.R., Guntur K.V., Erdjument-Bromage H., Tempst P., and Sabatini D.M. (2003). GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol. Cell 11, 895–904.
10. Jung C.H., Jun C.B., Ro S.H., Kim Y.M., Otto N.M., Cao J., Kundu M., and Kim D.H. (2009). ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol. Biol. Cell 20, 1992–2003.
11. He C., and Levine B. (2010). The Beclin 1 interactome. Curr. Opin. Cell Biol. 22, 140–149.
12. Ohsumi Y. (2001). Molecular dissection of autophagy: two ubiquitin-like systems. Nat. Rev. Mol. Cell Biol. 2, 211–216.
13. Kabeya Y., Mizushima N., Yamamoto A., Oshitani-Okamoto S., Ohsumi Y., and Yoshimori T. (2004). LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J. Cell Sci. 117, 2805–2812.
14. Kabeya Y., Mizushima N., Ueno T., Yamamoto A., Kirisako T., Noda T., Kominami E., Ohsumi Y., and Yoshimori T. (2000). LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19, 5720–5728.
15. Pickford F., Masliah E., Britschgi M., Lucin K., Narasimhan R., Jaeger P.A., Small S., Spencer B., Rockenstein E., Levine B., and Wyss-Coray T. (2008). The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J. Clin. Invest. 118, 2190–2199.
16. Ma J.F., Huang Y., Chen S.D., and Halliday G. (2010). Immunohistochemical evidence for macroautophagy in neurones and endothelial cells in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 36, 312–319.
17. Zhao Y.N., Guo X.F., Li J.M., Chen C.X., Li S.X., and Xu C.J. (2017). mTOR/autophagy pathway in the hippocampus of rats suffering intermittent hypoxia preconditioning and global cerebral ischemia-reperfusion. Oncotarget 8, 23353–23359.
18. Xu Y., Tian Y., Tian Y., Li X., and Zhao P. (2016). Autophagy activation involved in hypoxic-ischemic brain injury induces cognitive and memory impairment in neonatal rats. J. Neurochem. 139, 795–805.
19. Glover D., and Labadie E.L. (1976). Physiopathogenesis of subdural hematomas. Part 2: inhibition of growth of experimental hematomas with dexamethasone. J. Neurosurg. 45, 393–397.
20. Kageyama H., Toyooka T., Tsuzuki N., and Oka K. (2013). Nonsurgical treatment of chronic subdural hematoma with tranexamic acid. J. Neurosurg. 119, 332–337.
21. Osuka K., Watanabe Y., Usuda N., Aoyama M., Iwami K., Takeuchi M., Watabe T., and Takayasu M. (2017). Expression of caspase signaling components in the outer membranes of chronic subdural hematomas. J. Neurotrauma 34, 3192–3197.
22. Pattingre S., Tassa A., Qu X., Garuti R., Liang X.H., Mizushima N., Packer M., Schneider M.D., and Levine B. (2005). Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122, 927–939.
23. Pyo J.O., Jang M.H., Kwon Y.K., Lee H.J., Jun J.I., Woo H.N., Cho D.H., Choi B., Lee H., Kim J.H., Mizushima N., Oshumi Y., and Jung Y.K. (2005). Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death. J. Biol. Chem. 280, 20722–20729.
24. Yousefi S., Perozzo R., Schmid I., Ziemiecki A., Schaffner T., Scapozza L., Brunner T., and Simon H.U. (2006). Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat. Cell Biol. 8, 1124–1132.

Information & Authors

Information

Published In

cover image Journal of Neurotrauma
Journal of Neurotrauma
Volume 36Issue Number 2January 15, 2019
Pages: 403 - 407
PubMed: 30106666

History

Published in print: January 15, 2019
Published online: 27 December 2018
Published ahead of print: 14 August 2018

Permissions

Request permissions for this article.

Topics

Authors

Affiliations

Koji Osuka [email protected]
Department of Neurological Surgery, Aichi Medical University Aichi, Japan.
Yasuo Watanabe
High Technology Research Center, Pharmacology, Showa Pharmaceutical University, Tokyo, Japan.
Nobuteru Usuda
Department of Anatomy II, Fujita Health University School of Medicine, Aichi, Japan.
Masahiro Aoyama
Department of Neurological Surgery, Aichi Medical University Aichi, Japan.
Mikinobu Takeuchi
Department of Neurological Surgery, Aichi Medical University Aichi, Japan.
Masakazu Takayasu
Department of Neurological Surgery, Aichi Medical University Aichi, Japan.

Notes

Address correspondence to: Koji Osuka, MD, PhD, Department of Neurological Surgery, Aichi Medical University, Yazakokarimata, Nagakute, Aichi 480-1195, Japan [email protected]

Author Disclosure Statement

No competing financial interests exist.

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Get Access

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/ePub

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media

Back to Top